Accurexa, Inc. announced that on January 19, 2017, Mr. George Yu, MD resigned as President, Chief Executive Officer, Principal Financial Officer, and Director of the company's Board, effective immediately. Mr. Yu's resignation does not arise from any disagreement on any matter relating to the company's operations, policies or practices, or regarding the general direction of the company. On January 19, 2017, Mr. Anchie Kuo, MD resigned as Director of the company's Board, effective immediately.

Mr. Kuo's resignation does not arise from any disagreement on any matter relating to the company's operations, policies or practices, or regarding the general direction of the company. On January 19, 2017, the Board of Directors of the company appointed Mr. Bryan Lee, PhD as President, Chief Executive Officer, Principal Financial Officer, and Director of the company's Board, effective immediately. Mr. Lee has been Executive Director at Bright Oceans Ventures Ltd., a private investment firm focused on high-growth technology companies and special opportunities, since 2009.

He spent most of his 25-year professional career with growth and technology companies in the biotech, pharmaceutical and medical device industries. On January 19, 2017, the Board of Directors of the company appointed Mr. Oliver Jackson as Director of the company's Board, effective immediately. Mr. Jackson has been a partner at OMJ Asset Management S.A., a private equity firm, since 2003.

Previously, he was an investment banker for 14 years at Merrill Lynch and Lehman Brothers where worked on equity and debt financings, and cross-border M&A transactions for companies in the telecommunications and technology sectors.